ID: ALA2304276

Max Phase: Preclinical

Molecular Formula: C16H23N5Na2O14P2

Molecular Weight: 573.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1O[C@H](OP(=O)([O-])OP(=O)([O-])OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@@H](O)[C@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C16H25N5O14P2.2Na/c1-5-8(22)10(24)12(26)16(32-5)34-37(29,30)35-36(27,28)31-2-6-9(23)11(25)15(33-6)21-4-20-7-13(17)18-3-19-14(7)21;;/h3-6,8-12,15-16,22-26H,2H2,1H3,(H,27,28)(H,29,30)(H2,17,18,19);;/q;2*+1/p-2/t5-,6+,8-,9+,10-,11+,12-,15+,16+;;/m0../s1

Standard InChI Key:  MAIWPEAVJNGCPB-CBXQLZMWSA-L

Associated Targets(Human)

Galactoside 3(4)-L-fucosyltransferase 5 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fucosyltransferase 6 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 573.35Molecular Weight (Monoisotopic): 573.0873AlogP: -2.89#Rotatable Bonds: 8
Polar Surface Area: 291.52Molecular Species: ACIDHBA: 17HBD: 8
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.73CX Basic pKa: 4.92CX LogP: -5.85CX LogD: -8.37
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.15Np Likeness Score: 1.49

References

1. Baisch G, Ohrlein R, Katopodis A.  (1996)  Enzymatic fucosylations with purine-diphosphate-fucoses (PDP-Fucoses),  (24): [10.1016/S0960-894X(96)00543-4]

Source